InvestorsHub Logo
Followers 8
Posts 158
Boards Moderated 0
Alias Born 09/14/2014

Re: None

Sunday, 01/12/2020 12:02:05 PM

Sunday, January 12, 2020 12:02:05 PM

Post# of 27629
AMG

You keep whining that the same team is at AGN which went from breath testing for disease and decided to favour drug development. There isn't a market to fund a medical breath test but there is ample money to fund a Thc breathalyzer...Thus BLOZF has close to $10M in working capital and Breathtec was unable to raise money and had to switch to something they raised $2M on.

So give your head a shake and learn the real reasons decisions are made to abandon a technology and pursue something that can be funded. Owlstone does not have a working product and YOST is still very much travelling to Vancouver to consult on the BLOZF device, There is also no shared management on AGN and BLOZF.

BLOZF is developing a device and conserving cash and doing it professionally. As the CNN article states its not a simple task and HOUND does not have a single sale or a partnership with a law ebforcement agency to conduct trial to get approval of the device as a court certified EVIDENTIARY device. First to hit the road will be a BIG BIG winner and YOST and BLOZF are my picks
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BLOZF News